Bioequivalence of mirabegron 50 mg extended release Tablet [Design Issues]

posted by qualityassurance – 2022-08-04 17:47 (602 d 18:03 ago) – Posting: # 23202
Views: 2,502

Dear Ibrahim,

❝ Knowing that I couldn't find an accurate data for intrasubject variability of Mirabegnon.


I know it is very late response but here you can find the literature mentioning the high variability of mirabegron (approximately 33% to 45% for Cmax and 19% to 31% for AUC) AUS PAR.

Hope it may help other forum members.

Regards.

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
101 visitors (0 registered, 101 guests [including 6 identified bots]).
Forum time: 10:50 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5